Related Experiment Video
Updated: Jul 16, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention
Robert A Rosenheck1, Jeffrey A Lieberman
1Department of Psychiatry, Yale University School of Medicine and VA Northeast Program Evaluation Center, West Haven, Conn., USA.
Abstract:
Sales of atypical antipsychotics have expanded rapidly as their use for treatment of schizophrenia and other illnesses has increased. The CATIE trial was designed to evaluate the cost-effectiveness of these medications. Cost-effectiveness analysis in CATIE examined the benefits and costs of treatments and attempted to determine whether one treatment would result in better outcomes and lower costs than another one. While the data from CATIE on cost-effectiveness have not been analyzed yet, it is still possible to consider the potential implications of the analysis, including how the roles of researchers and stakeholders should be considered in deciding optimal clinical practices and public policies.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...